Get With the Guidelines Atrial Fibrillation Registry

Recruiting

• Conditions: Atrial Flutter; Atrial Fibrillation

• Registration Number: NCT06245187
• Lead Sponsor: American Heart Association

Brief Summary

Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Detailed Description

Get With The Guidelines-Atrial Fibrillation was initiated in 2013 with over 88 U.S. hospitals participating is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Achievement measures tracked through Get With The Guidelines-Atrial Fibrillation:

1. ACEI/ARB at discharge for LVSD

2. Assessment of thromboembolic risk factors

3. Beta Blocker at discharge

4. Discharged on FDA-approved anticoagulation therapy

5. PT/INR planned follow-up

6. Statin at discharge in AF patients with CAD, CVA/TIA or PVD.

Quality measures tracked through Get With The Guidelines-Atrial Fibrillation:

1. Aldosterone antagonist at discharge

2. Atrial fibrillation patient education

3. Anticoagulation therapy education

4. CHA2DS2-VASC reported

5. Discharge heart rate \<110bpm

6. Smoking cessation

7. Warfarin at discharge for valvular atrial fibrillation

Additional measures collected by Get With The Guidelines-Atrial Fibrillation can be viewed at: http://www.heart.org/idc/groups/heart-public/@private/@wcm/@hcm/@gwtg/documents/downloadable/ucm_451183.pdf

Study Timeline

• Study Start: 2013-01
• Study First Submitted: 2016-02-23
• Status Verified: 2024-01
• Study First Submitted QC: 2024-01-29
• Study First Posted: 2024-02-07
• Last Update Submitted: 2025-01-27
• Last Update Posted: 2025-01-29
• Primary Completion: 2040-01
• Study Completion: 2040-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 17198

Inclusion Criteria

• Patients hospitalized with nonvalvular Atrial Fibrillation or Atrial Flutter

Exclusion Criteria

• Patients who do not have nonvalvular Atrial Fibrillation or Atrial Flutter
• Patients under 18 years of age
• Patients not admitted as inpatients.
• Patients on comfort care only
• Patients discharged to hospice.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cardiac Tamponade and/or Pericardiocentesis Following Ablation	30 days	Percent of patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days following ablation procedure.

Trial Locations

Locations (1)

Amy Bennett; 🇺🇸 Dallas, Texas, United States